Visual Outcome of Intravitreal Bevacizumab in Treatment of Diabetic Retinopathy

Background :To evaluate the efficacy of monthly intravitreal bevacizumab injections (1.25 mg/.05 ml) in improving or stabilizing visual acuity measured by Snellen’s visual acuity charts for diabetic retinopathy. Methods: This was a prospective Quasi experimental study of 59 diabetic patients having...

Full description

Bibliographic Details
Main Authors: Kanwal Zareen Abbasi, Warda Ali, Qamar Farooq, Ali Raza, Ana Rizvi
Format: Article
Language:English
Published: Rawalpindi Medical University 2018-03-01
Series:Journal of Rawalpindi Medical College
Subjects:
Online Access:https://www.journalrmc.com/index.php/JRMC/article/view/840